• Something wrong with this record ?

Treatment Responses in Histologic Versus Molecular Diagnoses of Lung Rejection

A. Zajacova, M. Mackova, K. Halloran, P. Gauthier, J. Balko, M. Guney, D. Rakita, M. Svorcova, J. Kolarik, J. Vachtenheim, J. Pozniak, J. Simonek, L. Fila, R. Lischke, PF. Halloran, J. Havlin

. 2024 ; 37 (-) : 12847. [pub] 20240726

Language English Country Switzerland

Document type Journal Article, Comparative Study

Persistent link   https://www.medvik.cz/link/bmc24019677

Histologic evaluation of allograft biopsies after lung transplantation has several limitations, suggesting that molecular assessment using tissue transcriptomics could improve biopsy interpretation. This single-center, retrospective cohort study evaluated discrepancies between the histology of transbronchial biopsies (TBBs) with no rejection (NR) and T-cell mediated rejection (TCMR) by molecular diagnosis. The accuracy of diagnosis was assessed based on response to treatment. 54 TBBs from Prague Lung Transplant Program obtained between December 2015 and January 2020 were included. Patients with acute cellular rejection (ACR) grade ≥ 1 by histology received anti-rejection treatment. Response to therapy was defined as an increase in FEV1 of ≥ 10% 4 weeks post-biopsy compared to the pre-biopsy value. Among the 54 analyzed TBBs, 25 (46%) were concordant with histology, while 29 (54%) showed discrepancies. ACR grade 0 was found in 12 TBBs (22%) and grade A1 ≥ 1 in 42 TBBs (78%). Treatment response was present in 14% in the NR group and in 50% in the TCMR group (p = 0.024). Our findings suggest that low-grade acute cellular rejection is less likely to be associated with molecular TCMR, which might better identify lung transplant recipients who benefit from therapy.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24019677
003      
CZ-PrNML
005      
20241024110710.0
007      
ta
008      
241015e20240726sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/ti.2024.12847 $2 doi
035    __
$a (PubMed)39131792
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Zajacova, A $u Prague Lung Transplant Program, Department of Pneumology, Second Faculty of Medicine, Charles University, Motol University Hospital, Prague, Czechia
245    10
$a Treatment Responses in Histologic Versus Molecular Diagnoses of Lung Rejection / $c A. Zajacova, M. Mackova, K. Halloran, P. Gauthier, J. Balko, M. Guney, D. Rakita, M. Svorcova, J. Kolarik, J. Vachtenheim, J. Pozniak, J. Simonek, L. Fila, R. Lischke, PF. Halloran, J. Havlin
520    9_
$a Histologic evaluation of allograft biopsies after lung transplantation has several limitations, suggesting that molecular assessment using tissue transcriptomics could improve biopsy interpretation. This single-center, retrospective cohort study evaluated discrepancies between the histology of transbronchial biopsies (TBBs) with no rejection (NR) and T-cell mediated rejection (TCMR) by molecular diagnosis. The accuracy of diagnosis was assessed based on response to treatment. 54 TBBs from Prague Lung Transplant Program obtained between December 2015 and January 2020 were included. Patients with acute cellular rejection (ACR) grade ≥ 1 by histology received anti-rejection treatment. Response to therapy was defined as an increase in FEV1 of ≥ 10% 4 weeks post-biopsy compared to the pre-biopsy value. Among the 54 analyzed TBBs, 25 (46%) were concordant with histology, while 29 (54%) showed discrepancies. ACR grade 0 was found in 12 TBBs (22%) and grade A1 ≥ 1 in 42 TBBs (78%). Treatment response was present in 14% in the NR group and in 50% in the TCMR group (p = 0.024). Our findings suggest that low-grade acute cellular rejection is less likely to be associated with molecular TCMR, which might better identify lung transplant recipients who benefit from therapy.
650    _2
$a lidé $7 D006801
650    12
$a rejekce štěpu $x diagnóza $x patologie $7 D006084
650    12
$a transplantace plic $7 D016040
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé středního věku $7 D008875
650    _2
$a biopsie $7 D001706
650    _2
$a dospělí $7 D000328
650    _2
$a plíce $x patologie $7 D008168
650    _2
$a senioři $7 D000368
650    _2
$a výsledek terapie $7 D016896
650    _2
$a imunosupresiva $x terapeutické užití $7 D007166
655    _2
$a časopisecké články $7 D016428
655    _2
$a srovnávací studie $7 D003160
700    1_
$a Mackova, M $u Alberta Transplant Applied Genomics Centre, Edmonton, AB, Canada
700    1_
$a Halloran, K $u Department of Medicine, University of Alberta, Edmonton, AB, Canada
700    1_
$a Gauthier, P $u Alberta Transplant Applied Genomics Centre, Edmonton, AB, Canada
700    1_
$a Balko, J $u Department of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czechia
700    1_
$a Guney, M $u Second Faculty of Medicine, Charles University, Prague, Czechia
700    1_
$a Rakita, D $u Prague Lung Transplant Program, Department of Pneumology, Second Faculty of Medicine, Charles University, Motol University Hospital, Prague, Czechia
700    1_
$a Svorcova, M $u Prague Lung Transplant Program, 3rd Department of Surgery, First Faculty of Medicine, Charles University, Motol University Hospital, Prague, Czechia
700    1_
$a Kolarik, J $u Prague Lung Transplant Program, 3rd Department of Surgery, First Faculty of Medicine, Charles University, Motol University Hospital, Prague, Czechia
700    1_
$a Vachtenheim, J $u Prague Lung Transplant Program, 3rd Department of Surgery, First Faculty of Medicine, Charles University, Motol University Hospital, Prague, Czechia
700    1_
$a Pozniak, J $u Prague Lung Transplant Program, 3rd Department of Surgery, First Faculty of Medicine, Charles University, Motol University Hospital, Prague, Czechia
700    1_
$a Simonek, J $u Prague Lung Transplant Program, 3rd Department of Surgery, First Faculty of Medicine, Charles University, Motol University Hospital, Prague, Czechia
700    1_
$a Fila, L $u Prague Lung Transplant Program, Department of Pneumology, Second Faculty of Medicine, Charles University, Motol University Hospital, Prague, Czechia
700    1_
$a Lischke, R $u Prague Lung Transplant Program, 3rd Department of Surgery, First Faculty of Medicine, Charles University, Motol University Hospital, Prague, Czechia
700    1_
$a Halloran, P F $u Alberta Transplant Applied Genomics Centre, Edmonton, AB, Canada
700    1_
$a Havlin, J $u Prague Lung Transplant Program, 3rd Department of Surgery, First Faculty of Medicine, Charles University, Motol University Hospital, Prague, Czechia
773    0_
$w MED00004553 $t Transplant international : official journal of the European Society for Organ Transplantation $x 1432-2277 $g Roč. 37 (20240726), s. 12847
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39131792 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20241015 $b ABA008
991    __
$a 20241024110704 $b ABA008
999    __
$a ok $b bmc $g 2202109 $s 1231650
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 37 $c - $d 12847 $e 20240726 $i 1432-2277 $m Transplant international : official journal of the European Society for Organ Transplantation $n Transpl Int $x MED00004553
LZP    __
$a Pubmed-20241015
Back

Find record

Citation metrics

Archiving options